Yun Xing, BS

Tianjin University
Tianjin, ZheJiang

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2643 - Efficacy and Safety of Enzyme-Cleavable EGFR-MMAE Combined with Radiotherapy in Treating GBM: A Preclinical Phase Study

  Monday, September 30, 2024
  10:45 AM – 12:00 PM ET

• 2915 - Radiation-Induced Antigen Expression Benefits Tumor Uptake of ICAM1 Antibody-Drug Conjugates

  Monday, September 30, 2024
  5:00 PM – 6:00 PM ET